Projects

Co designing self care app in patients with Diabetes and Hypertension in an Indian Health care setting: Mixed methods study

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2021 - 2026

Project Lead

Bhuvana KB

Authors

Bhuvana KB, Bhuvaneshwari Sethuraman, Farah Naaz Fatima, Manjulika Vaz,

Project Status

ongoing

Project Type

Mixed methods